Warby Parker (WRBY) Stock Forecast, Price Target & Predictions
WRBY Stock Forecast
Warby Parker stock forecast is as follows: an average price target of $17.36 (represents a -25.40% downside from WRBY’s last price of $23.27) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
WRBY Price Target
The average price target for Warby Parker (WRBY) is $17.36 based on 1-year price targets from 14 Wall Street analysts in the past 3 months, with a price target range of $22.00 to $11.00. This represents a potential -25.40% downside from WRBY's last price of $23.27.
WRBY Analyst Ratings
According to 14 Wall Street analysts, Warby Parker's rating consensus is 'Buy'. The analyst rating breakdown for WRBY stock is 0 'Strong Buy' (0.00%), 9 'Buy' (64.29%), 5 'Hold' (35.71%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Warby Parker Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 08, 2024 | Anna Andreeva | Piper Sandler | $22.00 | $19.51 | 12.76% | -5.46% |
| Oct 29, 2024 | Paul Lejuez | Citigroup | $15.00 | $17.21 | -12.84% | -35.54% |
| Oct 21, 2024 | Brooke Roach | Goldman Sachs | $18.00 | $16.55 | 8.76% | -22.65% |
| Sep 27, 2024 | Ana Garcia | CFRA | $20.00 | $16.03 | 24.77% | -14.05% |
| Aug 23, 2024 | Nicholas Jones | JMP Securities | $20.00 | $13.86 | 44.30% | -14.05% |
| Aug 22, 2024 | Anna Andreeva | Piper Sandler | $18.00 | $13.86 | 29.87% | -22.65% |
| Aug 08, 2024 | Jim Duffy | Stifel Nicolaus | $15.00 | $14.04 | 6.84% | -35.54% |
| Jul 10, 2024 | Anthony Chukumba | Loop Capital Markets | $16.00 | $15.64 | 2.30% | -31.24% |
| May 10, 2024 | Anthony Chukumba | Loop Capital Markets | $15.00 | $15.03 | -0.20% | -35.54% |
| May 10, 2024 | Mark Carden | UBS | $15.00 | $15.33 | -2.15% | -35.54% |
The latest Warby Parker stock forecast, released on Nov 08, 2024 by Anna Andreeva from Piper Sandler, set a price target of $22.00, which represents a 12.76% increase from the stock price at the time of the forecast ($19.51), and a -5.46% decrease from WRBY last price ($23.27).
Warby Parker Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 2 | 6 | 11 |
| Avg Price Target | $18.50 | $18.83 | $17.55 |
| Last Closing Price | $23.27 | $23.27 | $23.27 |
| Upside/Downside | -20.50% | -19.08% | -24.58% |
In the current month, the average price target of Warby Parker stock is $18.50, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a -20.50% decrease as opposed to Warby Parker's last price of $23.27. This month's average price target is down -1.75% compared to last quarter, and up 5.41% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 08, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Nov 07, 2024 | William Blair | - | Outperform | Upgrade |
| Oct 29, 2024 | Citigroup | Neutral | Neutral | Hold |
| Oct 21, 2024 | Telsey Advisory | Market Outperform | Market Outperform | Hold |
| Oct 21, 2024 | Piper Sandler | Underperform | Underperform | Hold |
| Oct 21, 2024 | Goldman Sachs | - | Buy | Upgrade |
| Oct 03, 2024 | Loop Capital Markets | Hold | Hold | Hold |
| Sep 27, 2024 | CFRA | Buy | Buy | Hold |
| Aug 23, 2024 | Piper Sandler | Underperform | Underperform | Hold |
| Aug 23, 2024 | Telsey Advisory | Market Outperform | Market Outperform | Hold |
Warby Parker's last stock rating was published by Piper Sandler on Nov 08, 2024. The company gave WRBY a "Overweight" rating, the same as its previous rate.
Warby Parker Financial Forecast
Warby Parker Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $169.85M | $166.09M | $171.97M | $146.49M | $148.78M | $149.62M | $153.22M | $132.89M | $137.37M |
| Avg Forecast | $237.90M | $242.50M | $237.40M | $251.60M | $213.32M | $219.06M | $214.01M | $224.42M | $186.76M | $190.14M | $187.03M | $196.41M | $160.85M | $164.70M | $162.56M | $166.75M | $142.56M | $144.68M | $149.50M | $154.08M | $133.35M | $133.03M |
| High Forecast | $240.45M | $245.10M | $239.94M | $254.30M | $215.60M | $221.41M | $216.30M | $224.93M | $187.72M | $190.27M | $187.03M | $196.41M | $164.29M | $164.71M | $164.30M | $168.54M | $144.09M | $144.68M | $149.50M | $154.08M | $133.35M | $133.03M |
| Low Forecast | $235.97M | $240.53M | $235.47M | $249.56M | $211.58M | $217.28M | $212.27M | $223.91M | $185.82M | $190.01M | $187.03M | $196.41M | $159.15M | $164.69M | $161.24M | $165.39M | $141.41M | $144.68M | $149.50M | $154.08M | $133.35M | $133.03M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 9 | 4 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.02% | 1.03% | 1.03% | 1.03% | 1.00% | 0.99% | 1.00% | 1.03% |
Warby Parker's average Quarter revenue forecast for Dec 23 based on 9 analysts is $160.85M, with a low forecast of $159.15M, and a high forecast of $164.29M. WRBY's average Quarter revenue forecast represents a -5.30% decrease compared to the company's last Quarter revenue of $169.85M (Sep 23).
Warby Parker EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 9 | 4 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-19.77M | $-18.23M | $-3.29M | $-21.71M | $-15.74M | $-24.20M | $-26.60M | $-39.24M | $-86.48M |
| Avg Forecast | $-21.91M | $-22.34M | $-21.87M | $-23.17M | $-19.65M | $-20.18M | $-19.71M | $-20.67M | $-17.20M | $-17.51M | $-17.23M | $-18.09M | $-14.82M | $-15.17M | $-14.97M | $-15.36M | $-13.13M | $-13.53M | $-13.99M | $-14.41M | $-12.47M | $-12.44M |
| High Forecast | $-21.73M | $-22.15M | $-21.69M | $-22.99M | $-19.49M | $-20.01M | $-19.55M | $-20.62M | $-17.12M | $-17.50M | $-17.23M | $-18.09M | $-14.66M | $-15.17M | $-14.85M | $-15.23M | $-13.02M | $-13.53M | $-13.99M | $-14.41M | $-12.47M | $-12.44M |
| Low Forecast | $-22.15M | $-22.58M | $-22.10M | $-23.42M | $-19.86M | $-20.39M | $-19.92M | $-20.72M | $-17.29M | $-17.53M | $-17.23M | $-18.09M | $-15.13M | $-15.17M | $-15.13M | $-15.52M | $-13.27M | $-13.53M | $-13.99M | $-14.41M | $-12.47M | $-12.44M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.30% | 1.22% | 0.21% | 1.65% | 1.16% | 1.73% | 1.85% | 3.15% | 6.95% |
undefined analysts predict WRBY's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Warby Parker's previous annual EBITDA (undefined) of $NaN.
Warby Parker Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 9 | 4 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-17.41M | $-15.93M | $-10.81M | $-20.25M | $-23.84M | $-32.17M | $-34.13M | $-45.90M | $-91.07M |
| Avg Forecast | $12.09M | $4.84M | $8.46M | $10.88M | $5.32M | $6.60M | $9.73M | $12.82M | $3.26M | $6.33M | $6.25M | $8.21M | $807.52K | $941.46K | $2.78M | $5.44M | $-86.31K | $3.19M | $-2.53M | $522.26K | $-10.82M | $-62.79M |
| High Forecast | $12.26M | $4.90M | $8.58M | $11.03M | $5.40M | $6.69M | $9.86M | $13.00M | $6.51M | $6.47M | $6.27M | $8.21M | $826.86K | $954.58K | $2.82M | $5.51M | $-85.40K | $3.19M | $-2.53M | $522.26K | $-10.82M | $-62.79M |
| Low Forecast | $11.96M | $4.78M | $8.37M | $10.76M | $5.27M | $6.53M | $9.62M | $12.69M | $1.09M | $6.19M | $6.23M | $8.20M | $788.18K | $931.51K | $2.76M | $5.38M | $-87.52K | $3.19M | $-2.53M | $522.26K | $-10.82M | $-62.79M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -18.50% | -5.72% | -1.99% | 234.63% | -7.47% | 12.69% | -65.36% | 4.24% | 1.45% |
Warby Parker's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. WRBY's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Warby Parker SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 9 | 4 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $112.50M | $108.86M | $107.22M | $102.36M | $108.09M | $118.43M | $123.39M | $122.15M | $171.64M |
| Avg Forecast | $171.25M | $174.56M | $170.89M | $181.12M | $153.56M | $157.69M | $154.06M | $161.55M | $134.44M | $136.87M | $134.63M | $141.38M | $115.79M | $118.56M | $117.02M | $120.03M | $102.63M | $103.61M | $107.07M | $110.35M | $95.50M | $95.27M |
| High Forecast | $173.09M | $176.44M | $172.73M | $183.06M | $155.20M | $159.38M | $155.71M | $161.92M | $135.13M | $136.96M | $134.63M | $141.38M | $118.27M | $118.57M | $118.27M | $121.32M | $103.73M | $103.61M | $107.07M | $110.35M | $95.50M | $95.27M |
| Low Forecast | $169.86M | $173.15M | $169.50M | $179.64M | $152.31M | $156.41M | $152.80M | $161.18M | $133.77M | $136.78M | $134.63M | $141.38M | $114.56M | $118.55M | $116.07M | $119.06M | $101.79M | $103.61M | $107.07M | $110.35M | $95.50M | $95.27M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 0.93% | 0.89% | 1.00% | 1.04% | 1.11% | 1.12% | 1.28% | 1.80% |
Warby Parker's average Quarter SG&A projection for Dec 23 is $115.79M, based on 9 Wall Street analysts, with a range of $114.56M to $118.27M. The forecast indicates a 2.93% rise compared to WRBY last annual SG&A of $112.50M (Sep 23).
Warby Parker EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 9 | 4 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.15 | $-0.14 | $-0.09 | $-0.18 | $-0.21 | $-0.28 | $-0.30 | $-0.41 | $-1.45 |
| Avg Forecast | $0.10 | $0.04 | $0.07 | $0.09 | $0.04 | $0.05 | $0.08 | $0.11 | $0.03 | $0.05 | $0.05 | $0.07 | $0.01 | $0.01 | $0.02 | $0.04 | $-0.00 | $0.03 | $-0.02 | - | $-0.09 | $-0.52 |
| High Forecast | $0.10 | $0.04 | $0.07 | $0.09 | $0.04 | $0.06 | $0.08 | $0.11 | $0.05 | $0.05 | $0.05 | $0.07 | $0.01 | $0.01 | $0.02 | $0.05 | $-0.00 | $0.03 | $-0.02 | - | $-0.09 | $-0.52 |
| Low Forecast | $0.10 | $0.04 | $0.07 | $0.09 | $0.04 | $0.05 | $0.08 | $0.10 | $0.01 | $0.05 | $0.05 | $0.07 | $0.01 | $0.01 | $0.02 | $0.04 | $-0.00 | $0.03 | $-0.02 | - | $-0.09 | $-0.52 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -19.26% | -6.08% | -2.07% | 252.10% | -7.90% | 13.27% | -68.98% | 4.55% | 2.77% |
According to undefined Wall Street analysts, Warby Parker's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to WRBY previous annual EPS of $NaN (undefined).
Warby Parker Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| COO | Cooper Companies | $99.08 | $298.00 | 200.77% | Buy |
| ANGO | AngioDynamics | $6.74 | $15.00 | 122.55% | Buy |
| TFX | Teleflex | $187.43 | $304.36 | 62.39% | Buy |
| HAE | Haemonetics | $84.92 | $108.25 | 27.47% | Buy |
| BDX | Becton, Dickinson and Company | $222.39 | $283.27 | 27.38% | Buy |
| NVST | Envista | $20.37 | $23.11 | 13.45% | Hold |
| ALC | Alcon | $85.50 | $93.89 | 9.81% | Buy |
| BLFS | BioLife Solutions | $25.01 | $27.33 | 9.28% | Buy |
| HOLX | Hologic | $78.04 | $80.21 | 2.78% | Buy |
| ICUI | ICU Medical | $167.59 | $172.00 | 2.63% | Buy |
| MMSI | Merit Medical Systems | $104.08 | $100.78 | -3.17% | Buy |
| WST | West Pharmaceutical Services | $311.66 | $297.67 | -4.49% | Buy |
| RMD | ResMed | $241.55 | $219.13 | -9.28% | Hold |
| KRMD | KORU Medical Systems | $3.65 | $3.25 | -10.96% | Buy |
| LMAT | LeMaitre Vascular | $103.44 | $85.25 | -17.59% | Buy |
| ATR | AptarGroup | $168.73 | $138.00 | -18.21% | Buy |
| WRBY | Warby Parker | $23.27 | $17.36 | -25.40% | Buy |